The latest price target for Diversified Healthcare (NASDAQ:DHC) was reported by RBC Capital on October 14, 2024. The analyst firm set a price target for $3.00 expecting DHC to rise to within 12 months (a possible 24.48% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Diversified Healthcare (NASDAQ:DHC) was provided by RBC Capital, and Diversified Healthcare maintained their underperform rating.

There is no last upgrade for Diversified Healthcare

There is no last downgrade for Diversified Healthcare.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Diversified Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Diversified Healthcare was filed on October 14, 2024 so you should expect the next rating to be made available sometime around October 14, 2025.

While ratings are subjective and will change, the latest Diversified Healthcare (DHC) rating was a maintained with a price target of $2.00 to $3.00. The current price Diversified Healthcare (DHC) is trading at is $2.41, which is within the analyst’s predicted range.